World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
96
Citations
34927
World Ranking
9634
National Ranking
294

Research.com Recognitions

  • 2001 - Member of Academia Europaea

Overview

Pierre Ronco is affiliated with Sorbonne University in France and specializes predominantly in the field of Medicine, with a strong focus on Nephrology among other subfields such as Pathology and Forensic Medicine, Pulmonary and Respiratory Medicine, Molecular Biology, and Immunology.

Their research work primarily covers topics related to Renal Diseases and Glomerulopathies, Vasculitis and related conditions, Chronic Kidney Disease and Diabetes, Autoimmune Bullous Skin Diseases, Amyloidosis including diagnosis, treatment, and outcomes, the Complement system in diseases, and Systemic Sclerosis and Related Diseases.

Recent notable papers authored or co-authored by Pierre Ronco include:

  • Membranous nephropathy, 2021, published in Nature Reviews Disease Primers
  • KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases, 2021, Kidney International
  • Executive summary of the KDIGO 2021 Guideline for the Management of Glomerular Diseases, 2021, Kidney International
  • Nomenclature for kidney function and disease: report of a Kidney Disease: Improving Global Outcomes (KDIGO) Consensus Conference, 2020, Kidney International
  • The STARMEN trial indicates that alternating treatment with corticosteroids and cyclophosphamide is superior to sequential treatment with tacrolimus and rituximab in primary membranous nephropathy, 2020, Kidney International

The scientist has frequently published in the following venues:

  • Kidney International
  • Journal of the American Society of Nephrology
  • Kidney International Reports
  • American Journal of Kidney Diseases
  • Nephrology Dialysis Transplantation

Co-authorship collaborations often involve:

  • Brad H. Rovin
  • Hanna Dębiec
  • Germaine Wong
  • P Coates
  • Olivier Devuyst

Pierre Ronco was recognized as a Member of Academia Europaea in 2001.

Best Publications

  • Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): A consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis

    Morie A. Gertz;Ray Comenzo;Rodney H. Falk;Jean Paul Fermand

  • KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases

    Brad H. Rovin;Sharon G. Adler;Jonathan Barratt;Frank Bridoux

  • Nomenclature for kidney function and disease: report of a Kidney Disease: Improving Global Outcomes (KDIGO) Consensus Conference.

    Andrew S. Levey;Kai-Uwe Eckardt;Nijsje M. Dorman;Stacy L. Christiansen

  • Antenatal membranous glomerulonephritis due to anti-neutral endopeptidase antibodies.

    Hanna Debiec;Vincent Guigonis;Béatrice Mougenot;Fabrice Decobert

  • Risk HLA-DQA1 and PLA(2)R1 alleles in idiopathic membranous nephropathy

    H.C. Stanescu;M. Arcos-Burgos;A. Medlar;D. Bockenhauer

  • High-dose melphalan versus melphalan plus dexamethasone for AL amyloidosis.

    Arnaud Jaccard;Philippe Moreau;Véronique Leblond;Xavier Leleu

  • Executive summary of the KDIGO 2021 Guideline for the Management of Glomerular Diseases.

    Brad H. Rovin;Sharon G. Adler;Jonathan Barratt;Frank Bridoux

  • Fanconi syndrome and renal failure induced by tenofovir: a first case report.

    David Verhelst;Matthieu Monge;Jean-Luc Meynard;Bruno Fouqueray

  • COL4A1 mutations and hereditary angiopathy, nephropathy, aneurysms, and muscle cramps.

    Emmanuelle Plaisier;Olivier Gribouval;Sonia Alamowitch;Béatrice Mougenot

  • PLA2R autoantibodies and PLA2R glomerular deposits in membranous nephropathy

    Hanna Debiec;Pierre Ronco

  • Anti-Phospholipase A2 Receptor Antibody Titer Predicts Post-Rituximab Outcome of Membranous Nephropathy

    Piero Ruggenenti;Hanna Debiec;Hanna Debiec;Barbara Ruggiero;Antonietta Chianca

  • Antiphospholipase A2 Receptor Antibody Titer and Subclass in Idiopathic Membranous Nephropathy

    Julia M. Hofstra;Hanna Debiec;Hanna Debiec;Colin D. Short;Timotheé Pellé;Timotheé Pellé

  • Rituximab for Severe Membranous Nephropathy: A 6-Month Trial with Extended Follow-Up

    Karine Dahan;Hanna Debiec;Hanna Debiec;Emmanuelle Plaisier;Emmanuelle Plaisier;Marine Cachanado

  • Pathophysiological advances in membranous nephropathy: time for a shift in patient's care

    Pierre Ronco;Pierre Ronco;Hanna Debiec;Hanna Debiec

  • Rituximab treatment for severe steroid- or cyclosporine-dependent nephrotic syndrome: a multicentric series of 22 cases.

    Vincent Guigonis;Aymeric Dallocchio;Véronique Baudouin;Maud Dehennault

  • Proximal tubular cell synthesis and secretion of endothelin-1 on challenge with albumin and other proteins

    Carla Zoja;Carla Zoja;Marina Morigi;Marina Morigi;Marina Figliuzzi;Marina Figliuzzi;Isabella Bruzzi;Isabella Bruzzi

  • INF2 Mutations in Charcot–Marie–Tooth Disease with Glomerulopathy

    Olivia Boyer;Fabien Nevo;Emmanuelle Plaisier;Benoit Funalot

  • Microscopic polyangiitis with alveolar hemorrhage. A study of 29 cases and review of the literature. Groupe d'Etudes et de Recherche sur les Maladies "Orphelines" Pulmonaires (GERM"O"P).

    Dominique Lauque;Jacques Cadranel;Romain Lazor;Jacques Pourrat

  • Paraneoplastic glomerulopathies: New insights into an old entity

    Pierre M. Ronco

  • Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): a consensus opinion from th 10th International Symposium on Amyloid an Amyloidosis, Tours, France, 18-22 April 2004

    IT Istituto Superiore di Sanit;Grateau G;Solomon A;Sezer O

Frequent Co-Authors

Pierre J. Verroust
Pierre J. Verroust Aarhus University
Corinne Antignac
Corinne Antignac Institut Imagine
Giuseppe Remuzzi
Giuseppe Remuzzi Mario Negri Institute for Pharmacological Research
Laure-Hélène Noël
Laure-Hélène Noël Necker-Enfants Malades Hospital
Ariela Benigni
Ariela Benigni Mario Negri Institute for Pharmacological Research
Jack F.M. Wetzels
Jack F.M. Wetzels Radboud University
Sanjeev Sethi
Sanjeev Sethi Mayo Clinic

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a career in medicine doesn’t always mean becoming a doctor. Many alternative pathways offer rewarding roles in healthcare, often with shorter study times and flexible online options. For non-nurses looking to move quickly into advanced nursing roles, several direct entry msn programs for non nurses online are available, accepting students with undergraduate degrees in other fields.

Prospective nurses or those changing careers often seek accessible programs. Some institutions offer online bsn programs for non nurses, making it possible to transition into nursing without prior experience.

If you’re interested in the administrative side of healthcare, medical billing and coding is a promising field. It’s important to know: can you get financial aid for medical billing and coding studies? Many schools do offer support, making the field even more accessible.

Finally, some nursing schools eliminate common testing barriers. There are now accredited nursing schools that don’t require teas or hesi exams, helping more students enter the field without additional entrance tests.

Best Scientists Citing Pierre Ronco

Trending Scientists

Recently Published Articles